Filing detail
ENCORE MEDICAL CORP 10-K
Accession 0000950134-99-001893
Filed (ET)
Mar 23, 7:00 PM ET
Accepted
—
File size
398.3 KB
SEC accession
0000950134-99-001893
Filing details
- Company
- ReAble Therapeutics, Inc.
- CIK
- 0000944763
- Incorporated
- DE
- Entity type
- operating
Related parties
- filerCIK 0000944763
Documents
10-K
FORM 10-K FOR FISCAL YEAR END DECEMBER 31, 1998
PrimaryOpen file ↗EX-10.19
EMPLOYMENT AGREEMENT - GREG KASEESKA
EX-10.20
SEVERANCE AGREEMENT - GREG KASEESKA
EX-10.21
EMPLOYMENT AGREEMENT - KATHY WIEDERKEHR
EX-10.22
SEVERANCE AGREEMENT - KATHY WIEDERKEHR
EX-10.23
EMPLOYMENT AGREEMENT - ROBERT R. BUCKLEY, JR.
EX-10.24
SERVERANCE AGREEMENT - ROBERT R. BUCKLEY, JR.
EX-10.25
EMPLOYMENT AGREEMENT - JEAN-PAUL BURTIN
EX-10.26
SEVERANCE AGREEMENT - JEAN-PAUL BURTIN
EX-10.27
2ND AMENDMENT TO SEVERAGE AGREEMENT-NICK CINDRICH
EX-10.28
2ND AMENDMENT TO SEVERAGE AGREEMENT-CRAIG SMITH
EX-10.29
2ND AMENDMENT TO SEVERANCE AGREEMENT-AUGUST FASKE
EX-10.30
2ND AMENDMENT TO SEVERAGE AGREEMENT-H L ZIMMERMAN
EX-10.31
2ND AMENDMENT TO SEVERAGE AGREEMENT-K. LUDWIG, JR.
EX-10.32
2ND AMENDMENT TO SEVERANCE AGREEMENT-J.D. WEBB, JR
EX-10.33
AMENDMENT TO SEVERANCE AGREEMENT-GREG KASEESKA
EX-10.34
AMENDMENT TO SEVERANCE AGREEMENT-KATHY WIEDERKEHR
EX-21
SUBSIDIARIES OF THE REGISTRANT
EX-27
FINANCIAL DATA SCHEDULE